Gary S. Francis

Q: What Schools Are Affiliated With Gary S. Francis

Gary S. Francis is affiliated with the following schools: University of Minnesota, Case Western Reserve University, University of Glasgow

Gary S. Francis's AcademicInfluence.com Rankings

Gary S. Francis

Medical

#1423

World Rank

#1760

Historical Rank

Cardiology

#109

World Rank

#111

Historical Rank

medical Degrees

Gary S. Francis

Philosophy

#4510

World Rank

#7055

Historical Rank

Logic

#1946

World Rank

#2823

Historical Rank

philosophy Degrees

Download Badge

Medical
Philosophy

Gary S. Francis's Degrees

Doctorate Medicine Harvard University
PhD Cardiology Stanford University

Why Is Gary S. Francis Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Gary S. Francis's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult—Summary Article (2005) (5001)
Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. (1984) (3153)
ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. (2002) (2786)
A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. (1991) (2732)
The effect of digoxin on mortality and morbidity in patients with heart failure. (1997) (2495)
Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study. (1986) (1910)
2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults (2009) (1575)
Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD). (1990) (1426)
Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. (2009) (1281)
Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure. Results of a Veterans Administration Cooperative Study (1987) (1108)
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes. (2007) (720)
Guidelines for the evaluation and management of heart failure. Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Evaluation and Management of Heart Failure). (1995) (684)
2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement. (2012) (672)
Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure. (1982) (638)
Decision Making in Advanced Heart Failure: A Scientific Statement From the American Heart Association (2012) (623)
The neurohumoral axis in congestive heart failure. (1984) (622)
Impaired chronotropic response to exercise stress testing as a predictor of mortality. (1999) (583)
Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure. Activation of the neurohumoral axis. (1985) (535)
Increased plasma arginine vasopressin levels in patients with congestive heart failure. (1983) (484)
Current Diagnostic and Treatment Strategies for Specific Dilated Cardiomyopathies: A Scientific Statement From the American Heart Association. (2016) (445)
Cardiac troponins in renal insufficiency: review and clinical implications. (2002) (414)
Heart failure, chronic diuretic use, and increase in mortality and hospitalization: an observational study using propensity score methods. (2006) (413)
Consensus recommendations for the management of chronic heart failure: Introduction (1999) (391)
Elevated intra-abdominal pressure in acute decompensated heart failure: a potential contributor to worsening renal function? (2008) (387)
Prognostic Significance of Serial Changes in Left Ventricular Ejection Fraction in Patients With Congestive Heart Failure (1993) (385)
BNP Consensus Panel 2004: A clinical approach for the diagnostic, prognostic, screening, treatment monitoring, and therapeutic roles of natriuretic peptides in cardiovascular diseases. (2004) (376)
National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: analytical issues for biochemical markers of acute coronary syndromes. (2007) (376)
Animal models of heart failure: a scientific statement from the American Heart Association. (2012) (372)
Characterization and prognostic value of persistent hyponatremia in patients with severe heart failure in the ESCAPE Trial. (2007) (336)
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical utilization of cardiac biomarker testing in heart failure. (2007) (333)
Prognostic significance of plasma norepinephrine in patients with asymptomatic left ventricular dysfunction. SOLVD Investigators. (1996) (315)
Neurohormonal activation in patients with right ventricular failure from pulmonary hypertension: relation to hemodynamic variables and endothelin levels. (1995) (305)
Pathophysiologic targets in the early phase of acute heart failure syndromes. (2005) (286)
Recommendations for the Use of Mechanical Circulatory Support: Device Strategies and Patient Selection A Scientific Statement From the American Heart Association (2012) (262)
Acute heart failure syndromes: emergency department presentation, treatment, and disposition: current approaches and future aims: a scientific statement from the American Heart Association. (2010) (250)
Noninvasive evaluation of cardiac function in hypothyroidism. Response to gradual thyroxine replacement. (1977) (248)
Plasma B-Type Natriuretic Peptide Levels in Ambulatory Patients With Established Chronic Symptomatic Systolic Heart Failure (2003) (240)
Ventilatory and heart rate responses to exercise : better predictors of heart failure mortality than peak oxygen consumption. (1999) (238)
Effect of short-term infusion of sodium nitroprusside on mortality rate in acute myocardial infarction complicated by left ventricular failure: results of a Veterans Administration cooperative study. (1982) (237)
Decreased SLIM1 Expression and Increased Gelsolin Expression in Failing Human Hearts Measured by High-Density Oligonucleotide Arrays (2000) (233)
Contributory Risk and Management of Comorbidities of Hypertension, Obesity, Diabetes Mellitus, Hyperlipidemia, and Metabolic Syndrome in Chronic Heart Failure: A Scientific Statement From the American Heart Association. (2016) (229)
Newly Diagnosed and Previously Known Diabetes Mellitus and 1-Year Outcomes of Acute Myocardial Infarction: The Valsartan in Acute Myocardial Infarction (VALIANT) Trial (2004) (229)
Use of the Living With Heart Failure questionnaire to ascertain patients' perspectives on improvement in quality of life versus risk of drug-induced death. (1995) (229)
Nitroprusside in critically ill patients with left ventricular dysfunction and aortic stenosis. (2003) (228)
Detection of soluble angiotensin-converting enzyme 2 in heart failure: insights into the endogenous counter-regulatory pathway of the renin-angiotensin-aldosterone system. (2008) (224)
Antibody-mediated rejection in cardiac transplantation: emerging knowledge in diagnosis and management: a scientific statement from the American Heart Association. (2015) (195)
The prognostic value of estimated creatinine clearance alongside functional capacity in ambulatory patients with chronic congestive heart failure. (2002) (193)
Relationship of exercise capacity to resting left ventricular performance and basal plasma norepinephrine levels in patients with congestive heart failure. (1982) (190)
Development of arrhythmias in the patient with congestive heart failure: pathophysiology, prevalence and prognosis. (1986) (183)
Soluble angiotensin-converting enzyme 2 in human heart failure: relation with myocardial function and clinical outcomes. (2009) (181)
Predicting survival for an individual with congestive heart failure using the plasma norepinephrine concentration. (1987) (181)
Adverse effects of combination angiotensin II receptor blockers plus angiotensin-converting enzyme inhibitors for left ventricular dysfunction: a quantitative review of data from randomized clinical trials. (2007) (181)
Response of plasma norepinephrine and epinephrine to dynamic exercise in patients with congestive heart failure. (1982) (180)
Neurohumoral mechanisms involved in congestive heart failure. (1985) (176)
Pathophysiology of chronic heart failure. (2001) (174)
Bradykinin antagonism inhibits the antigrowth effect of converting enzyme inhibition in the dog myocardium after discrete transmural myocardial necrosis. (1995) (174)
Neurohumoral control mechanisms in congestive heart failure. (1981) (171)
Prompt reduction in intra-abdominal pressure following large-volume mechanical fluid removal improves renal insufficiency in refractory decompensated heart failure. (2008) (170)
Evaluation and long-term prognosis of new-onset, transient, and persistent anemia in ambulatory patients with chronic heart failure. (2008) (160)
Fluid retention after initiation of thiazolidinedione therapy in diabetic patients with established chronic heart failure. (2003) (155)
An international perspective on heart failure and left ventricular systolic dysfunction complicating myocardial infarction: the VALIANT registry. (2004) (154)
Sodium nitroprusside for advanced low-output heart failure. (2008) (146)
Plasma B-Type Natriuretic Peptide Levels Predict Postoperative Atrial Fibrillation in Patients Undergoing Cardiac Surgery (2004) (144)
Ventilatory and Heart Rate Responses to Exercise Better Predictors of Heart Failure Mortality Than Peak Oxygen Consumption (1999) (138)
Rationale, design, implementation, and baseline characteristics of patients in the DIG trial: a large, simple, long-term trial to evaluate the effect of digitalis on mortality in heart failure. (1996) (125)
Relative attenuation of sympathetic drive during exercise in patients with congestive heart failure. (1985) (124)
Veterans Administration Cooperative Study on Vasodilator Therapy of Heart Failure: influence of prerandomization variables on the reduction of mortality by treatment with hydralazine and isosorbide dinitrate. (1987) (123)
2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement: developed in collabration with the American Heart Association, American Society of Echocardiography, European Association for Cardio-Thoracic Surgery, Heart Failure Society of America, Mended Hearts, Society (2012) (123)
Predictors of mortality in patients with heart failure and preserved systolic function in the Digitalis Investigation Group trial. (2003) (123)
Effect of long-term enalapril therapy on neurohormones in patients with left ventricular dysfunction (1995) (115)
Optimizing therapy for complex or refractory heart failure: a management algorithm. (1998) (114)
Hemodynamic effects of infused arginine vasopressin in congestive heart failure. (1986) (113)
Neurohumoral activation in preclinical heart failure. Remodeling and the potential for intervention. (1993) (112)
National Academy of Clinical Biochemistry Laboratory Medicine practice guidelines: Clinical utilization of cardiac biomarker testing in heart failure. (2008) (108)
Arginine vasopressin and the renal response to water loading in congestive heart failure. (1986) (107)
The relationship of the sympathetic nervous system and the renin-angiotensin system in congestive heart failure. (1989) (102)
Memory improvement following cardiac transplantation. (1997) (101)
ST-segment elevation myocardial infarction: recommendations on triage of patients to heart attack centers: is it time for a national policy for the treatment of ST-segment elevation myocardial infarction? (2006) (100)
Predictors of the first heart failure hospitalization in patients who are stable survivors of myocardial infarction complicated by pulmonary congestion and/or left ventricular dysfunction: a VALIANT study. (2008) (99)
The pathophysiology of advanced heart failure. (1999) (95)
Comparative hemodynamic effects of dopamine and dobutamine in patients with acute cardiogenic circulatory collapse. (1982) (95)
Demonstration of exercise-induced painless myocardial ischemia in survivors of out-of-hospital ventricular fibrillation. (1987) (94)
The autonomic nervous system in congestive heart failure. (1986) (94)
ACE inhibition in cardiovascular disease. (2000) (93)
Clinical aspects of heart failure (1986) (90)
Heart failure therapy at a crossroad: are there limits to the neurohormonal model? (2003) (89)
Response of vasopressin and norepinephrine to lower body negative pressure in humans. (1982) (88)
Angiotensin-converting enzyme inhibition and beta-adrenoceptor blockade regress established ventricular remodeling in a canine model of discrete myocardial damage. (1994) (88)
HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction--pharmacological approaches. Heart Failure Society of America. (2000) (81)
Aspirin and clopidogrel in acute coronary syndromes: therapeutic insights from the CURE study. (2003) (80)
Recommendations for the Use of Mechanical Circulatory Support: Ambulatory and Community Patient Care: A Scientific Statement From the American Heart Association. (2017) (78)
ACCF/AHA/ACP/HFSA/ISHLT 2010 clinical competence statement on management of patients with advanced heart failure and cardiac transplant: a report of the ACCF/AHA/ACP Task Force on Clinical Competence and Training. (2010) (76)
2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement: developed in collaboration with the American Heart Association, American Society of Echocardiography, European Association for Cardio-Thoracic Surgery, Heart Failure Society of America, Mended Hearts, Societ (2012) (76)
The effects of bromocriptine in patients with congestive heart failure. (1983) (75)
Enhanced external counterpulsation improves exercise tolerance in patients with chronic heart failure. (2006) (75)
Effect of captopril on renal function in patients with congestive heart failure. (1981) (75)
Outcomes of patients with stable heart failure undergoing elective noncardiac surgery. (2008) (74)
Cardiac Calcitropes, Myotropes, and Mitotropes: JACC Review Topic of the Week. (2019) (74)
Cardiovascular impact in patients undergoing maintenance hemodialysis: Clinical management considerations. (2017) (72)
ALLogeneic Heart STem Cells to Achieve Myocardial Regeneration (ALLSTAR) Trial: Rationale and Design (2017) (71)
Regional blood flow response to orthostasis in patients with congestive heart failure. (1983) (70)
National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine practice guidelines: Analytical issues for biomarkers of heart failure. (2008) (70)
Hemodynamic, left ventricular structural and hormonal changes after discrete myocardial damage in the dog. (1992) (68)
Two-dimensional echocardiographic demonstration of left atrial thrombi in patients with prosthetic mitral valves. (1979) (67)
Long-term oral nitrate therapy prevents chronic ventricular remodeling in the dog. (1993) (64)
Sequential neurohumoral measurements in patients with congestive heart failure. (1988) (63)
Autologous cell transplantation for the treatment of damaged myocardium. (2002) (62)
Rapid, accurate and simultaneous noninvasive assessment of right and left ventricular mass with nuclear magnetic resonance imaging using the snapshot gradient method. (1992) (59)
A New Pathway (2007) (59)
Neurohormonal response to left ventricular reconstruction surgery in ischemic cardiomyopathy. (2004) (58)
Intracoronary ALLogeneic heart STem cells to Achieve myocardial Regeneration (ALLSTAR): a randomized, placebo-controlled, double-blinded trial. (2020) (58)
Assessment of Left Ventricular Function in Severe Aortic Regurgitation (1976) (57)
Disparate effects of the calcium-channel blockers, nifedipine and verapamil, on alpha 2-adrenergic receptors and thromboxane A2-induced aggregation of human platelets. (1986) (53)
Apoptosis, Bcl-2, and proliferating cell nuclear antigen in the failing human heart: observations made after implantation of left ventricular assist device. (1999) (53)
A Test in Context: Critical Evaluation of Natriuretic Peptide Testing in Heart Failure. (2016) (52)
Accuracy of echocardiography for assessing aortic root diameter. (1975) (52)
The pathophysiology of advanced heart failure. (1998) (52)
Cardiopulmonary exercise variables in diastolic versus systolic heart failure. (2008) (52)
Changing the remodeling process in heart failure: basic mechanisms and laboratory results. (1998) (52)
Heterogeneous myocardial catecholamine concentrations in patients with congestive heart failure. (1987) (52)
Modulation of peripheral sympathetic nerve transmission. (1988) (51)
Pathophysiologic aspects of end-stage heart failure. (1995) (49)
Pirbuterol: a new oral sympathomimetic amine for the treatment of congestive heart failure. (1981) (48)
Coronary-artery surgery in patients with end-stage renal disease. (1980) (45)
Beta-adrenergic receptors and calcium cycling proteins in non-failing, hypertrophied and failing human hearts: transition from hypertrophy to failure. (2001) (45)
Elevated left ventricular myocardial dopamine in preterminal idiopathic dilated cardiomyopathy. (1983) (45)
Neuroendocrine activity in congestive heart failure. (1990) (43)
Influence of prerandomization (baseline) variables on mortality and on the reduction of mortality by enalapril. Veterans Affairs Cooperative Study on Vasodilator Therapy of Heart Failure (V-HeFT II). V-HeFT VA Cooperative Studies Group. (1993) (42)
Acute decompensated heart failure: the cardiorenal syndrome. (2006) (42)
Neuroendocrine manifestations of congestive heart failure. (1988) (42)
Clinical competence in insertion of a temporary transvenous ventricular pacemaker. A statement for physicians from the ACP/ACC/AHA Task Force on Clinical Privileges in Cardiology. (1994) (42)
Marked spontaneous improvement in ejection fraction in patients with congestive heart failure. (1990) (42)
2012 ACCF/AATS/SCAI/STS Expert Consensus Document on Transcatheter Aortic Valve Replacement (2012) (42)
Neurohumoral activation and progression of heart failure: hypothetical and clinical considerations. (1998) (41)
Hemodynamic and neurohumoral responses to dynamic exercise: normal subjects versus patients with heart disease. (1987) (41)
Pathophysiology of congestive heart failure. (2003) (41)
Heart rate response during dipyridamole stress as a predictor of mortality in patients with normal myocardial perfusion and normal electrocardiograms. (2005) (39)
Aldosterone receptor antagonists in the medical management of chronic heart failure. (2005) (39)
Should asymptomatic ventricular arrhythmias in patients with congestive heart failure be treated with antiarrhythmic drugs? (1988) (39)
Left ventricular hypertrophy: an initial response to myocardial injury. (1992) (38)
Calcium channel blockers and congestive heart failure. (1991) (37)
Cardiac troponins and chronic kidney disease. (2006) (37)
Induction and maintenance of an experimental model of severe cardiomyopathy with a novel protocol of rapid ventricular pacing. (2002) (36)
Maximal exercise tolerance as a therapeutic end point in heart failure--are we relying on the right measure? (1994) (36)
The data monitoring experience in the MOXCON trial. (2004) (36)
Update on COVID-19 Myocarditis (2020) (36)
ACCF/AHA/ACP/HFSA/ISHLT 2010 clinical competence statement on management of patients with advanced heart failure and cardiac transplant: a report of the ACCF/AHA/ACP Task Force on Clinical Competence and Training. (2010) (35)
Catheter ablation of hemodynamically unstable ventricular tachycardia with mechanical circulatory support. (2013) (35)
Normal catecholamine and hemodynamic responses to orthostatic tilt in subjects with mitral valve prolapse. Correlation with psychologic testing. (1985) (35)
Effect of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Antagonists in Atherosclerosis Prevention (2012) (35)
Effect of long-term enalapril therapy on neurohormones in patients with left ventricular dysfunction. SOLVD Investigators. (1995) (34)
Usefulness of Isosorbide Dinitrate and Hydralazine as add-on therapy in patients discharged for advanced decompensated heart failure. (2009) (34)
TNF-α and Heart Failure The Difference Between Proof of Principle and Hypothesis Testing (1999) (34)
Primary cardiac lymphoma treated with orthotopic heart transplantation: a case report. (1994) (33)
Effect of increased intracardiac and arterial pressure on plasma vasopressin in humans. (1984) (33)
Myocardial bioenergetic abnormalities in a canine model of left ventricular dysfunction. (1994) (33)
Phosphodiesterase 5 inhibition in heart failure: mechanisms and clinical implications (2009) (30)
Prognostic evaluation of ambulatory patients with advanced heart failure. (2008) (30)
Left ventricular diastolic properties and filling characteristics during spontaneous angina pectoris at rest. (1983) (30)
Treating heart failure with enhanced external counterpulsation (EECP): design of the Prospective Evaluation of EECP in Heart Failure (PEECH) trial. (2005) (30)
Adverse drug reactions in patients with cardiovascular disease. (2008) (30)
A new, precise definition of acute myocardial infarction (2009) (29)
Gender differences in patients admitted with advanced decompensated heart failure. (2008) (28)
HFSA guidelines for the management of patients with heart failure due to left ventricular systolic dysfunction--pharmacological approaches. (2000) (28)
Determinants of prognosis in patients with heart failure. (1994) (28)
Enhanced external counterpulsation improves exercise duration and peak oxygen consumption in older patients with heart failure: a subgroup analysis of the PEECH trial. (2006) (28)
Attenuation of the pressor response to intravenous furosemide by angiotensin converting enzyme inhibition in congestive heart failure. (1989) (28)
A phase II, double-blind, randomized, placebo-controlled, dose comparative study of the efficacy, tolerability, and safety of MCC-135 in subjects with chronic heart failure, NYHA class II/III (MCC-135-GO1 study): rationale and design. (2004) (28)
Impaired response of plasma vasopressin to orthostatic stress in patients with congestive heart failure. (1983) (28)
Cardiac troponins in renal insufficiency and other non-ischemic cardiac conditions. (2004) (27)
Hemodynamic, renal, and neurohumoral effects of a selective oral DA1 receptor agonist (fenoldopam) in patients with congestive heart failure. (1988) (27)
Why do patients fail to receive β-blockers for chronic heart failure over time? A “real-world” single-center, 2-year follow-up experience of β-blocker therapy in patients with chronic heart failure (2005) (27)
Statin treatment for patients with heart failure (2010) (27)
Predicting adverse events during angiotensin receptor blocker treatment in heart failure: results from the HEAAL trial (2012) (27)
Influence of Prerandomization (Baseline) Variables on Mortalit and on the Reduction of Mortalit by Enalapril Veterans Affairs Cooperative Study on Vasodilator Therapy of Heart Failure (V‐HeFT II) (1993) (27)
A hard look at angiotensin receptor blockers in heart failure. (2004) (27)
Nitroglycerin and nitrate esters. (1978) (26)
Effects of sodium nitroprusside in aortic stenosis associated with severe heart failure: pressure-volume loop analysis using a numerical model. (2005) (26)
Trends in patient selection for heart transplantation. (1993) (26)
Cardiac function in mild and severe primary hypothyroidism. (1982) (25)
Cardiac safety profile of patients receiving high cumulative doses of pegylated-liposomal doxorubicin: use of left ventricular ejection fraction is of unproven value (2017) (25)
Cardiac failure: a revised paradigm. (1995) (24)
Flecainide (R-818), a new antiarrhythmic agent: Effects on ventricular premature beats (1978) (24)
Norepinephrine infusions in congestive heart failure. (1985) (23)
Post-infarction myocardial remodelling: why does it happen? (1995) (23)
Clinical competence in insertion of a temporary transvenous ventricular pacemaker. ACP/ACC/AHA Task Force on Clinical Privileges in Cardiology. (1994) (23)
Vasopressin receptor antagonists: will the "vaptans" fulfill their promise? (2004) (23)
Advanced heart failure and transplant cardiology: a subspecialty is born. (2009) (22)
Left ventricular function during spontaneous angina pectoris: effect of sublingual nitroglycerin. (1980) (22)
Neurohormonal control of heart failure (2011) (22)
Drug Insight: aldosterone-receptor antagonists in heart failure—the journey continues (2007) (22)
Plasma renin activity in patients with heart failure and reduced ejection fraction on optimal medical therapy (2017) (21)
Interaction of the sympathetic nervous system and electrolytes in congestive heart failure. (1990) (21)
Free and conjugated plasma catecholamines in patients with congestive heart failure. (1984) (21)
Vasodilators in the intensive care unit. (1991) (21)
Atrial fibrillation and heart failure: intersecting populations, morbidities, and mortality (2013) (20)
A review of the haemodynamic effects of labetalol in man. (1982) (20)
Clinical outcomes of patients with impaired left ventricular ejection fraction undergoing autologous bone marrow transplantation: can we safely transplant patients with impaired ejection fraction? (2004) (20)
Polypharmacy of heart failure. Creating a rational pharmacotherapeutic protocol. (2001) (20)
Effect of delayed intervention with ACE-inhibitor therapy on myocyte hypertrophy and growth of the cardiac interstitium in the rat model of myocardial infarction. (1997) (20)
Risk stratification for patients undergoing nonurgent percutaneous coronary intervention using N-terminal pro-B-type natriuretic peptide: a Clopidogrel for the Reduction of Events During Observation (CREDO) substudy. (2007) (19)
The acute response of plasma norepinephrine, renin activity, and arginine vasopressin to short-term nitroprusside and nitroprusside withdrawal in patients with congestive heart failure. (1983) (18)
Effect of head-down tilt on basal plasma norepinephrine and renin activity in humans. (1985) (18)
The year in heart failure. (2005) (18)
Histamine, mast cells, and heart failure: is there a connection? (2006) (17)
Racial analysis of patients with myocardial infarction complicated by heart failure and/or left ventricular dysfunction treated with valsartan, captopril, or both. (2008) (17)
Neuro-ophthalmic findings in progressive multifocal leukoencephalopathy. (1998) (17)
AHA Scientific Statement Acute Heart Failure Syndromes : Emergency Department Presentation , Treatment , and Disposition : Current Approaches and Future Aims (2010) (17)
Prognostic factors affecting diagnosis and treatment of congestive heart failure. (1989) (16)
Medical management of terminal cardiomyopathy (1982) (16)
The contemporary use of digoxin for the treatment of heart failure. (2008) (15)
Aldosterone inhibition and heart failure: too good to be true? (2001) (15)
Beta-blockers and reverse remodeling: what are the implications? (2003) (14)
Novel pharmacological treatments for heart failure (2003) (14)
Compensatory and maladaptive responses to cardiac dysfunction. (1994) (14)
Long-term effects of a once-a-day versus twice-a-day regimen of enalapril for congestive heart failure. (1989) (14)
Why do patients fail to receive beta-blockers for chronic heart failure over time? A "real-world" single-center, 2-year follow-up experience of beta-blocker therapy in patients with chronic heart failure. (2005) (14)
Neurohormonal upregulation in heart failure. (2005) (13)
Combining neuroendocrine inhibitors in heart failure: reflections on safety and efficacy. (2007) (13)
Pathophysiology of congestive heart failure secondary to congestive and ischemic cardiomyopathy. (1988) (13)
Reflex control of osmotically stimulated vasopressin in normal humans. (1985) (13)
The year in heart failure. (2008) (13)
Comparative sensitivities between different plasma B-type natriuretic peptide assays in patients with minimally symptomatic heart failure. (2005) (13)
Interaction of intravenous atrial natriuretic factor with furosemide in patients with heart failure. (1994) (12)
Modern Coronary Care (1990) (12)
Advanced heart failure and transplant cardiology: a subspecialty is born. (2009) (12)
National academy of clinical biochemistry laboratory medicine practice guidelines: Point of care testing, oversight, and administration of cardiac biomarkers for acute coronary syndromes (2007) (12)
TNF-alpha and heart failure. The difference between proof of principle and hypothesis testing. (1999) (12)
Testing for B-type natriuretic peptide in the diagnosis and assessment of heart failure: what are the nuances? (2004) (12)
Congestive Cardiac Failure: Pathophysiology and Treatment (1993) (12)
Echocardiographic criteria of normal left atrial size in adults. (1976) (12)
Cardiac complications in the intensive care unit. (1999) (11)
The difficult task of evaluating how to monitor patients with heart failure. (2005) (11)
Heart failure management: the impact of drug therapy on survival. (1988) (11)
Manual of Coronary Care (1980) (10)
Should we consider aldosterone as the primary screening target for preventing cardiovascular events? (2005) (10)
Acute heart failure: patient management of a growing epidemic. (2004) (10)
Vasodilators and inotropic agents in the treatment of congestive heart failure. (1994) (10)
Extracardiac features of heart failure: catecholamines and hormonal changes. (1988) (10)
Arterial vascular compliance response to exercise in hypertension. (1988) (9)
Safety of hot and cold liquids in patients with acute myocardial infarction. (1977) (9)
The looming polypharmacy crisis in the management of patients with heart failure. Potential solutions. (2001) (9)
The pathophysiology of advanced heart failure (Reprinted from Am Heart J, vol 135, pg S216-S230, 1998) (1999) (9)
Notice of concern. (2013) (9)
Neurohumoral variability in left ventricular dysfunction (1995) (9)
Compensatory and maladaptive responses to cardiac dysfunction. (1994) (8)
Irregular pupil cycling as a characteristic abnormality in patients with demyelinative optic neuropathy. (1988) (8)
Contractile reserve: are we beginning to understand it? (2008) (8)
Heart failure in 1991. (1991) (8)
Diagnosis and Management of Acute Congestive Heart Failure in the Intensive Care Unit (1989) (8)
Spironolactone in chronic heart failure:all's well that ends well. (2003) (8)
Mechanism of death in patients with congestive cardiac failure: the change in plasma norepinephrine and its relation to sudden death. (1990) (7)
Anemia and heart failure a new pathway? (2007) (7)
Early cardiac resynchronization therapy and reverse remodeling in patients with mild heart failure: is it time? (2009) (7)
It is all about heart rate. Or is it? (2012) (7)
Heart Failure with Preserved Ejection Fraction (HFpEF) (2017) (7)
Adenosine potentiates the inhibitory effects of calcium channel antagonists on human platelet aggregation induced by thromboxane A2 or U46619. (1990) (6)
Routine statin treatment after acute coronary syndromes? (2002) (6)
Nuggets, pearls, and vignettes of master heart failure clinicians. Part 4--treatment. (2002) (6)
Nitroglycerin, nitroprusside and endothelium-derived relaxing factor. (1988) (6)
Cholesterol and Heart Failure: Is There an Important Connection? (2017) (6)
Cardiac resynchronization therapy in New York Heart Association class IV heart failure: it is all about selection. (2006) (6)
Sodium and water excretion in heart failure: efficacy of treatment has surpassed knowledge of pathophysiology. (1986) (5)
Is there still a future for neutral endopeptidase inhibitors? (1999) (5)
Serial evaluation for left ventricular thrombus during acute transmural myocardial infarction using two-dimensional echocardiography (2DE) (1980) (5)
Congestive heart failure. New frontiers. (1991) (5)
Clinical Evaluation of Heart Failure (2011) (5)
Trends and treatment of heart failure developing after acute myocardial infarction. (2003) (5)
Heart failure and/or left ventricular systolic dysfunction complicating myocardial infarction is common and accounts for the majority of in-hospital myocardial infarction mortality: Results of the VALIANT registry (2003) (5)
AHA Scientific Statement Recommendations for the Use of Mechanical Circulatory Support : Device Strategies and Patient Selection (2012) (5)
Nitroprusside infusion in acute myocardial infarction. (2009) (5)
In heart failure, all beta-blockers are not necessarily equal. (2003) (4)
Physiologic determinants of survival in congestive heart failure. The survival hypothesis: how small uncontrolled studies should influence the design of large-scale clinical trials. (1987) (4)
Danger in Nitroprusside Therapy (1976) (4)
Promising small molecule for heart failure targeting adrenal catecholamine release and β-adrenergic receptor signaling in the heart. (2014) (4)
B-Type Natriuretic Peptides in Acute Coronary Syndromes (2004) (4)
Calcium channel antagonists inhibit epinephrine potentiation of thromboxane A2-induced human platelet aggregation (1981) (4)
From B-type natriuretic peptide to green mambas: the process of discovery. (2008) (4)
Hypothetical pathways of cardiac myocyte hypertrophy: response to myocardial injury. (1993) (4)
Statement From the American Heart Association Treatment, and Disposition: Current Approaches and Future Aims. A Scientific Acute Heart Failure Syndromes: Emergency Department Presentation, (2010) (4)
Vasopressin receptor antagonists in the management of acute heart failure (2005) (4)
Practicing 'check the box' medicine. (2013) (4)
Furosemide Reimagined: Novel Subcutaneous Formulation for a 50-Year-Old Loop Diuretic Agent for the Treatment of Acute Decompensated Heart Failure. (2017) (3)
Pathophysiology of chronic heart failure. Discussion (2001) (3)
The use of angiotensin-converting enzyme inhibitors in the treatment and prevention of congestive heart failure. (1993) (3)
557 Prompt reduction in Intra‐Abdominal Pressure following large‐volume mechanical fluid removal improves renal insufficiency in refractory decompensated Heart Failure (2008) (3)
The Heart Failure Society of America in 2020: a vision for the future. (2012) (3)
Cardiac Calcitropes, Myotropes, andMitotropes (3)
Cardiac failure and the autonomic nervous system (2013) (3)
Contemporary management and research directions in advanced heart failure: where are we going? (2011) (3)
Force on Practice Guidelines, International Society for Heart and Lung American College of Cardiology Foundation/American Heart Association Task Management of Heart Failure in Adults 2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and (2009) (3)
Beta-blockers and ACE inhibitors: New data, old myths (2000) (3)
Role of echocardiography in emergencies. (1980) (3)
Healed Myocardial Infarction (2012) (2)
Heart Failure Care Delivery in the COVID-19 Era: The Patients’ Perspective (2021) (2)
Neurohormones in Congestive Heart Failure (1993) (2)
Effect of captopril on renal function in congestive heart failure (1980) (2)
Highlights of the 2006 scientific sessions of the Heart Failure Society of America: Seattle, Washington, September 10-13, 2006. (2007) (2)
1088-127 Hypotension associated with nesitride infusion in patients with decompensated heart failure is related to large volume diuresis: Implications for monitoring and dose adjustments (2004) (2)
Force on Practice Guidelines, International Society for Heart and Lung American College of Cardiology Foundation/American Heart Association Task Diagnosis and Management of Heart Failure in Adults 2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the (2009) (2)
PEER REVIEWED PUBLICATIONS 1. Ali YS, Maron DJ. Screening for coronary disease in diabetes: when and how. Clin Diabetes 2006; 24:169- 173. (2007) (2)
The role of ACE inhibitors in preventing myocardial infarction: potential mechanisms and clinical implications. (1995) (2)
β-blockers in stage B: a precursor of heart failure. (2012) (2)
On being smart. The value of creativity in research. (2012) (2)
Plasma arginine vasopressin in hyponatremic patients with heart failure. (1981) (2)
Natriuretic peptides and renal insufficiency: clinical significance and role of renal clearance. (2006) (2)
50th anniversary historical article. Heart failure. (1999) (2)
What are 'tissue ACE inhibitors,' and should they be used instead of other ACE inhibitors? (2001) (2)
Exploring new drugs for heart failure: the case of urocortin. (2007) (2)
Evolving concepts in left ventricular systolic and diastolic remodeling: Implications for therapy (2004) (2)
Heart Failure as a Consequence of Hypertension (2011) (2)
Handbook of Coronary Care (1993) (2)
AHA Scientific Statement Decision Making in Advanced Heart Failure (2012) (2)
Angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers in chronic heart failure [2] (multiple letters) (2005) (2)
Heart Association Decision Making in Advanced Heart Failure : A Scientific Statement From the American Print (2012) (2)
Which drug for what patient with heart failure, and when? (1989) (2)
Diet in the coronary care unit. (1978) (2)
Management of heart failure: a brief review and selected update. (2008) (2)
Aortic Valve Replacement 2012 ACCF/AATS/SCAI/STS Expert Consensus Document on Transcatheter (2012) (2)
ACCF/AHA Practice Guideline: Focused Update Practice Guideline: Focused Update 2009 Focused Update: ACCF/AHA Guidelin s for the Diagnosis and Management of Heart Failure in Adults (2009) (2)
The End Is Near... Do We Know Everything About Cardiopulmonary Exercise Testing in HF Patients? (2016) (1)
552 Using B-type natriuretic peptide (BNP) in ambulatory patients with chronic heart failure and concomitant chronic renal insufficiency (2003) (1)
Does the underlying etiology influence plasma B-type natriuretic peptide levels of patients with isolated chronic aortic regurgiation and preserved left ventricular function? (2004) (1)
Lack of effect of associated myocardial infarction on long-term survival of out-of-hospital ventricular fibrillation (1980) (1)
The sympathetic response to exercise in patients with congestive heart failure (1981) (1)
Plasma BNP concentration predicted the presence of heart failure. (1998) (1)
Heart failure : frontiers in cardiology (2000) (1)
Impact of known and newly diagnosed diabetes mellitus after a myocardial infarction (2003) (1)
Modifiable Risk Factors for Stroke in High-Risk Patients following Acute Myocardial Infarction: Insights from the VALIANT Study (2004) (1)
Fibrinolytic therapy in the elderly: making sense of troubling new findings. (2000) (1)
Natural History of Cardiac Remodeling (2005) (1)
Emerging data from heart failure trials: clinical application. (1998) (1)
Neurohumoral variability in left ventricular dysfunction. SOLVD Investigators. Studies of Left Ventricular Dysfunction. (1995) (1)
Guidelines: Clinical Utilization of Cardiac Biomarker Testing in Heart Failure National Academy of Clinical Biochemistry Laboratory Medicine Practice (2008) (1)
Patterns and outcomes of revascularization in patients with heart failure and/or left ventricular systolic dysfunction following acute myocardial infarction: observations from the VALIANT registry (2004) (1)
Pharmacologic treatment of congestive heart failure with standard drugs (1993) (1)
Left ventricular function during exercise and following nitroglycerin in patients with acute recurrent pulmonary edema of clinically undefined etiology (1979) (1)
Comparison of radionuclide and contrast techniques in assessing ejection fraction at rest and during exercise (1980) (1)
Syndromes of Acute Left Ventricular Failure (1991) (1)
Effect ofcaptopril onrenal function inpatients with congestive heart failure (1981) (1)
Right ventricular infarction: recognition, treatment, and nursing considerations. (1980) (1)
Acute cardiac pulmonary edema: Evaluation and management (1989) (1)
Adjunctive medical therapy for acute coronary syndromes. (2000) (1)
555 Importance of venous congestion for worsening of renal function in advanced decompensated heart failure (2008) (1)
Chronic Heart Failure: 10 Questions Physicians Often Ask (2002) (1)
Conjugated plasma norepinephrine in patients with congestive heart failure (1982) (1)
INITIATION AND EVALUATION OF AN INTENSIVE INSULIN PROTOCOL IN THE CRITICALLY ILL: 456 (2004) (1)
Neurohumoral and hemodynamic response to bromocriptine in patients with congestive heart failure (1982) (1)
Creating a Rational Pharmacotherapeutic Protocol (2001) (1)
FAILURE WRITING ON BEHALF OF THE 2005 HEART FAILURE WRITING GUIDELINE FOR THE MANAGEMENT OF PATIENTS WITH CHRONIC HEART (2009) (1)
Clinical outcomes of patients with impaired left ventricular ejection fraction undergoing autologous bone marrow transplantation (2003) (1)
Angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers in chronic heart failure. (2005) (1)
B-type natriuretic peptide predicts left ventricular response to surgery in patients with severe mitral regurgitation in asymptomatic patients with preserved left ventricular function (2003) (1)
In vivo interaction of AR-L 115BS (Vardax) with the adrenergic nervous system. (1984) (1)
On writing with young people. (2013) (1)
Novel Therapies in Heart Failure (2007) (1)
50th anniversary historical article. Heart failure. (2000) (1)
Rotating tourniquets for acute cardiogenic pulmonary edema. (1995) (1)
Fluid retention with thiazolidinediones in diabetic heart failure (2003) (1)
Stage B, a pre-cursor of heart failure. (2012) (1)
I recently received a letter from my cardiologist, and among other diagnoses listed was "sick sinus syndrome." What does this mean? (2002) (0)
Ask Dr. Francis. A catheterization revealed a severe narrowing in one of my coronary arteries. My cardiologist recommended that I return for an angioplasty and stent procedure. Should I wait until coated stents are available? (2002) (0)
Subject Index, Vol. 75, 1988 (1988) (0)
Hemodynamic effects and elimination of infused norepinephrine in patients with congestive heart failure (1982) (0)
Comparative measurement of plasma B-type natriuretic peptide (BNP) and N-terminal pro-BNP in the clinical setting: pilot observations (2003) (0)
Plasma Renin Activity in Distinct Patient Populations with Heart Failure and Reduced Ejection Fraction (2016) (0)
Heart failure/transplantAbstractsPredictors of mortality in patients with heart failure (HF) and preserved systolic function in the Digitalis Investigation Group (DIG) trial (2004) (0)
With Chronic Heart Failure Enhanced External Counterpulsation Improves Exercise Tolerance in Patients (2006) (0)
Is There a Role in Routine Biomarker Screening for Cardiotoxicity in Patients Receiving Doxorubicin Chemotherapy? Pilot Observations (2006) (0)
T-Segment Elevation Myocardial nfarction : Recommendations on riage of Patients to Heart Attack Centers s it Time for a National Policy for the reatment of ST-Segment Elevation Myocardial Infarction ? (2006) (0)
Editorship Changes Hands (2010) (0)
for Biomarkers of Heart Failure Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: Analytical Issues National Academy of Clinical Biochemistry and IFCC Committee for Standardization of (2013) (0)
Limitations of echocardiography in measuring left ventricular ejection fraction in cornary artery disease. A comparision of M-mode systolic time intervals and a two-dimensional technique with radionuclide ventriculography (1987) (0)
nhanced External ounterpulsation Improves Exercise olerance in Patients With Chronic Heart Failure (2006) (0)
During a routine physical, my doctor performed a chest x-ray. He said it showed I have an enlarged heart. What made him say this and should I be worried? (2002) (0)
Using plasma B-type natriuretic peptide levels to monitor ambulatory patients with chronic heart failure and concomitant renal insufficiency (2003) (0)
It is an honor to serve (2004) (0)
I have arthritis and take ibuprofen. Can ibuprofen cause heart failure? (2002) (0)
Abstract Twenty-third annual scientific session American College of Cardiology New York, New York, February 11 to 14, 1973The accuracy of the continuous echocardiographic recording method for assessing aortic root size (1974) (0)
I have tried everything I can think of to lose weight on my own and am now thinking of using weight-loss medications. Are they safe? (2002) (0)
Sustained Reduction in Symptoms Related to Reduction of Filling Pressures during Hospitalization for Heart Failure (2006) (0)
History of heart failure and left ventricular ejection fraction strongly predicts adverse outcomes among patients undergoing contemporary percutaneous coronary intervention: insights from TARGET (2003) (0)
Heart failure post-myocardial infarction in the new millennium: how often does it occur, can we predict it, and what are the consequences? (2004) (0)
Heart Failure: A Case-Based Approach, Peter S. Rahko, MD, Demos Medical, 2013 (2014) (0)
INABILITY TO REACH 85% OF AGE-PREDICTED HEART RATE DURING EXERCISE STRESS TEST PREDICTS MORTALITY: (1999) (0)
Hypotensive Response on Cardiopulmonary Stress Test is Associated with Increased Hospitalization Length of Stay Following Orthotopic Heart Transplantation (2021) (0)
Is the combination of valsartan and captopril better than captopril alone in patients with heart failure and left ventricular systolic dysfunction after myocardial infarction? results of VALIANT (2004) (0)
General Treatment of Diastolic Heart Failure (2008) (0)
ACE inhibitors in the treatment of congestive heart failure: Overview (1995) (0)
Spironolactone inchronic heart failure:all’s well that ends well**Editorials published in the Journal of the American College of Cardiologyreflect the views of the authors and do not necessarily represent the views of JACCor the American College of Cardiology. (2003) (0)
Chapter-01 Vasodilators and Neurohormone Modulators (2015) (0)
function in the Digitalis Investigation Group trial Predictors of mortality in patients with heart failure and preserved systolic (2011) (0)
Vasodilator Therapy of Heart Failure: influence of prerandomization variables (2005) (0)
1138-65 Identification of risk factors for in-hospital complications in patients with severe left ventricular dysfunction undergoing percutaneous coronary intervention (2004) (0)
Manual de cuidados coronarios (1981) (0)
Isosorbide Dinitrate and Hydralazine as Add-On Therapy in Patients Admitted with Advanced Decompensated Heart Failure (2008) (0)
Epidemiology of congestive heart failure and results of recent drug intervention studies (1992) (0)
I have severe coronary artery disease and have been receiving chelation therapy. When I mentioned this to my doctor, he said I was wasting my money, and that I ought to stop. What do you think? (2002) (0)
Recent developments in vasodilator therapy for heart failure (1991) (0)
Treatment of the patient with heart failure: Recommendations of the ACC/AHA Task Force for the Evaluation and Management of Heart Failure (1996) (0)
Ask Dr. Francis. I recently had a stroke and was told that the only possible cause the doctors could find was plaque protruding into my aorta. What can be done about this? (2002) (0)
I read recently that patients with heart disease are more likely to develop dementia. How can I prevent dementia as I age? (2002) (0)
Enhancement ofTactile Perception inPalpation (1980) (0)
The influence of drug therapy on survival in patients with congestive heart failure (1988) (0)
Prevalence and clinical characteristics of patients with chronic systolic heart failure and normal plasma levels of B-type natriuretic peptide (2003) (0)
Angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers in chronic heart failure. Authors' reply (2005) (0)
Left ventricular hypertrophy : an initial response to myocardial injury. Discussion (1992) (0)
Episiotomy and faecal incontinence (1999) (0)
Routine statin treatment after acute coronary (2002) (0)
Enhanced External Counterpulsation nhanced External ounterpulsation Improves Exercise olerance in Patients With Chronic Heart Failure (2006) (0)
Therapeutic aspects of heart failure (1987) (0)
Almost daily I have read about advances in genetics. Will this translate into better treatments for heart disease? (2002) (0)
The year in heart failure. (2006) (0)
Ask Dr. Francis. I am taking a medication called rofecoxib for knee arthritis, and it works well. But I've heard reports that this type of medication may be dangerous for people with heart disease. Should I be worried? (2002) (0)
1030-8 Changes in β-Actin mRNA Expression in a Canine Model of Left Ventricular Remodeling (1995) (0)
Ask the doctors. I live in a city with high air pollution. Is this a risk factor for heart disease? (2003) (0)
Cardiac safety profile of patients receiving high cumulative doses of pegylated-liposomal doxorubicin (PLD): Use of left ventricular ejection fraction (EF). (2016) (0)
Risk stratification for patients undergoing elective percutaneous coronary intervention using plasma N-terminal pro-B-type natriuretic peptide assay: a clopidogrel for reduction of events during observation (CREDO) sub-study (2004) (0)
Therapeutic strategies in congestive heart failure-update in pathophysiology-emergence of a new model (1998) (0)
Factors affecting recovery of left ventricular function after mitral valve surgery (1978) (0)
The role of vasodilators in heart failure (1992) (0)
Stage B, a precursor of heart failure, part II. (2012) (0)
Exercise testing for patients with heart failure (1995) (0)
The acute effects of nitroprusside on plasma norepinephrine, renin activity, and arginine vasopressin in patients with congestive heart failure (1982) (0)
Hypotensive Response on Cardiopulmonary Stress Test Predicts Elevated Pulmonary Capillary Wedge Pressure and Reduced Cardiac Output in Patients Undergoing Evaluation for Left Ventricular Assist Device (2020) (0)
I was experiencing shortness of breath and my doctor sent me to a cardiologist. He performed an echocardiogram. The diagnosis was "diastolic dysfunction." What's the significance. (2002) (0)
Cost-effectiveness of Newer Antiplatelet Drugs [3] (multiple letters) (2003) (0)
Practice Guidelines : Clinical Utilization of Cardiac Biomarker Testing in Heart Failure WRITING GROUP MEMBERS (2007) (0)
Utility of B-type natriuretic peptide in primary diastolic dysfunction: A quantitative comparison with Doppler echocardiographic indices (2003) (0)
Remembering Philip A. Poole-Wilson, Helmut Drexler, and Kenneth L. Baughman (2010) (0)
Case 19: Data Monitoring Experience in the Moxonidine Congestive Heart Failure Trial (2006) (0)
A REVIEW OFTHEHAEMODYNAMIC EFFECTSOFLABETALOL INMAN (1982) (0)
The year in heart failure. (2007) (0)
Cost-effectiveness of newer antiplatelet drugs. Authors' reply (2003) (0)
Ask Dr. Francis. My doctor informed me that my kidneys have started to fail. How does this affect my risk for heart disease? (2002) (0)
Left ventricular dysfunction: diagnostic aspects and prognostic implications. (1995) (0)
Book ReviewCardiovascular Therapy: A systematic approach Vasodilator Therapy for Cardiac Disorders (1980) (0)
353 Gender differences in patients admitted with advanced decompensated heart failure (2008) (0)
I've got atrial fibrillation. What can you tell me about the Maze procedure? Would it be useful for me? (2002) (0)
Heart failure/transplant abstractThe prognostic value of estimated creatinine clearance alongside functional capacity in ambulatory patients with chronic congestive heart failure☆ (2003) (0)
Comprar Stage B, a Pre-cursor of Heart Failure, An Issue of Heart Failure Clinics | Jay N. Cohn | 9781455738717 | Saunders (2012) (0)
Drugs Blocking the Renin-Angiotensin-Aldosterone System (2004) (0)
Letter: Danger in nitroprusside therapy. (1976) (0)
Clusters of differential gene expression of structural proteins between failing and nonfailing hearts: preliminary insights from oligonucleotide microarrays (2002) (0)
Inpharzam medical forum--'heart failure today'. (1988) (0)
The year in heart failure. (2005) (0)
Autonomic biology: From beheaded animals to a spate of nobel prizes (2006) (0)
Soluble Angiotensin Converting Enzyme 2 Is Released in Patients with Heart Failure (2007) (0)
PHARMACOMECHANICAL APPROACH TO CHF TREATMENT Pathophysiology of Congestive Heart Failure (0)
Coronary revascularization for treatment of heart failure: optimal patient selection (2004) (0)
Optimizing Clinical Outcomes in Acute Decompensated Heart Failure (2009) (0)
Ask Dr. Francis. I read recently that people with diabetes are at high risk for cardiovascular disease. I have diabetes, but am not aware of any other health problems. What can I do to reduce my risk? (2002) (0)
The Characteristics of Out-Patient Use of Intravenous Milrinone in the United States (2019) (0)
Brain natriuretic peptide concentration was effective for screening for LV systolic dysfunction. (1998) (0)
Advanced Decompensated Heart Failure Importance of Venous Congestion for Worsening of Renal Function in (2009) (0)
SYSTEM IN CONGESTIVE HEART FAILURE (1986) (0)
Relation of Cystatin C to Natriuretic Peptide, Creatinine Clearance, and Prognosis in Patients with Chronic Systolic Heart Failure (2006) (0)
INCREASED EXHALED NITRIC OXIDE LEVELS IN AMBULATORY PATIENTS WITH CHRONIC SYSTOLIC HEART FAILURE FOLLOWING EXERCISE: IMPORTANCE OF PULMONARY VENOUS HYPERTENSION (2010) (0)
Role of invasive monitoring in heart failure: Pulmonary artery catheters in the post-ESCAPE era (2012) (0)
CALCIUM ANTAGONISTS Disparate effects of the calcium-channel blockers , nifedipine and verapamil , on a 2-adrenergic receptors and thromboxane A 2-induced aggregation of human platelets (2005) (0)
Patient Selection : A Scientific Statement From the American Heart Association Recommendations for the Use of Mechanical Circulatory Support: Device Strategies and (2012) (0)
Reply: applying cluster analysis to data of previously published chronic heart failure trials. (2015) (0)
I have just been diagnosed with an overactive thyroid. What are the risks to my heart? (2002) (0)
I have congested heart failure and I was recently diagnosed with sleep apnea. Are the two connected? (2002) (0)
Disparate effects ofthecalcium-channel blockers, nifedipine andverapamil, on a2-adrenergic receptors andthromboxane A2-induced aggregation (1986) (0)
On the interaction between grapefruit juice and cardiovascular medications (1999) (0)
Abstract 2560: Reduction of Filling Pressures During Hospitalization Predicts Sustained Reduction in Heart Failure Symptoms (2006) (0)
Document on Transcatheter Aortic Valve Replacement (2012) (0)
Aha Scientific Statement Antibody-mediated Rejection in Cardiac Transplantation: Emerging Knowledge in Diagnosis and Management a Scientific Statement from the American Heart Association Endorsed by the International Society for Heart and Lung Transplantation (0)
Cardiac troponins and chronic kidney disease. Authors' reply (2006) (0)
In praise of idleness. (2011) (0)
Hypotensive Response on Cardiopulmonary Stress Test is Associated with Increased One Year Mortality After Continuous Flow Left Ventricular Assist Device Implantation (2020) (0)
821-6 Beta-blocker utilization in patients with heart failure: A single-center, two-year follow-up (2004) (0)
analysis using a numerical model loop associated with severe heart failure: pressure-volume Effects of sodium nitroprusside in aortic stenosis (2013) (0)
Vasodilators and congestive heart failure (1987) (0)
Where have all the clinical trials gone? (2011) (0)
Neurohormones in Advanced Heart Failure (2000) (0)
PCSK9 inhibitors and their use in advanced heart failure and heart transplant recipients (2020) (0)
Pathophysiology of the spectrum of acute heart failure: de novo heart failure, decompensated heart failure, and advanced refractory heart failure (2005) (0)
Ask the doctors. I have prominent varicose veins on both legs. They hurt, and I don't like how they look. How can I get rid of them? (2003) (0)
Sudden death and heart failure (1990) (0)
Neurohumoral features of cardiac failure (1988) (0)
How important is it to drink eight glasses of water every day? I try to do that, but often am able to get only about six glasses in. (2002) (0)
Ask the doctors. My doctor said recently that I have pre-diabetes. What does that mean? (2003) (0)
Current insights and new treatment options in heart failure. (1998) (0)
AHA/ACC Updates in the Treatment of Patients with Heart Failure (2013) (0)
Predicting Adverse Effects during Angiotensin Receptor Blocker Treatment in Heart Failure: Results from the HEAAL Trial (2010) (0)
Release of Soluble Angiotensin Converting Enzyme 2 into the Plasma of Patients with Chronic Systolic Heart Failure Is Not Related to Systemic Inflammation (2008) (0)
I have been told that I have very weak heart muscle that is causing heart failure. I saw a special on television about implantable pumps. Could one of these help me? (2002) (0)
Vasoactive Drugs and the Failing Ventricle (1985) (0)
Prevalence and clinical significance of “transient anemia” in ambulatory patients with chronic heart failure (2004) (0)
The 9th annual scientific meeting of the Heart Failure Society of America [6] (2005) (0)
Telemonitoring and Contemporary Outpatient Management of Patients with Heart Failure: Is it Time? (2018) (0)
Plasma B-type natriuretic peptide levels in chronic heart failure (2004) (0)
Spironolactone in addition to standard therapy reduced the risk of mortality and morbidity in patients with severe HF (1999) (0)
Cellular and subcellular basis for remodeling: summation. (2002) (0)
Selected Reports from the Ninth Annual Scientifi c Meeting of the Heart Failure Society of America (2006) (0)
A 34-year-old man with facial droop and dysarthria. (2003) (0)
HFSA President's Editorial It Is an Honor to Serve (2004) (0)
In reply: Acute myocardial infarction (March 2009) (2009) (0)
Type II Pulmonary Hypertension in the Setting of Heart Failure with Preserved Ejection Fraction (2020) (0)
Response of vasopressin to increased central venous and arterial pressure in normal man (1982) (0)
Response to ‘Cardiac troponins and chronic kidney disease’ (2006) (0)
I am a male in my late 50s. I have heart disease and erectile dysfunction. Are the two related? (2002) (0)
Ari Cedars Giovanni Filardo (2017) (0)
Cost-effectiveness analysis and clinical practice. (1995) (0)
Hail and Farewell. (2014) (0)
COVID cardiomyopathy: Is it time to involve the cardiologists? (2020) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Gary S. Francis?

Gary S. Francis is affiliated with the following schools:

Gary S. Francis's Academic­Influence.com Rankings

Gary S. Francis's Degrees

Why Is Gary S. Francis Influential?

Gary S. Francis's Published Works

Published Works

What Schools Are Affiliated With Gary S. Francis?

Gary S. Francis's AcademicInfluence.com Rankings